Fieldpoint Private Securities, LLC Argenx Se Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Argenx Se stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 439 shares of ARGX stock, worth $283,874. This represents 0.05% of its overall portfolio holdings.
Number of Shares
439
Previous 440
0.23%
Holding current value
$283,874
Previous $139,000
19.42%
% of portfolio
0.05%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding ARGX
# of Institutions
422Shares Held
31.1MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.76 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.27 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.6 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.1 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$801 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...